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INTERESTING MEDICAL IMAGE 
 
Figure 1: Infiltrated erythematous nodules on the 
anterior aspect of the left leg with severe hyperkeratosis 
and secondary impetiginisation.
An 83-year-old woman, with a past medical history of hypertension, diabetes mellitus and ischemic cardiomyopathy, 
was referred to the dermatology clinic of Complejo 
Hospitalario de Jaen in Jaen, Spain, in October 2013. 
The patient presented with erythematous indurated 
tumoural lesions with severe hyperkeratosis and 
impetiginisation on the anterior aspect of her left 
leg, which had appeared eight months prior [Figure 
1]. Fever, night sweats, weight loss, itching or other 
constitutional symptoms were absent. Neither 
hepatosplenomegaly nor axillary or generalised 
lymphadenopathy were detected. A systemic 
examination of the patient did not reveal any further 
abnormalities.
All laboratory tests were negative, including a full 
blood count; biochemistry, protein electrophoresis, 
routine urine, lactate dehydrogenase, β2-
microglobulin and immunoglobulin tests; a peripheral 
blood smear, and serology tests for viruses (human 
immunodeficiency virus and hepatitis B and C 
viruses) and Borrelia burgdorferi. No evidence of 
malignancy was observed during a whole-body 
computed tomography scan or a bone marrow biopsy. 
A cutaneous biopsy was also performed.
A histological examination of the skin specimen 
revealed a B-lymphocyte proliferation with mild 
epidermotropism and antigen CD20/45 positivity. 
The following profile was obtained from an 
immunohistochemical assay: positive multiple 
myeloma oncogene 1 (MUM-1), positive B-cell 
lymphoma 6 (Bcl-6), negative chromosome 10 (C10), 
positive B-cell lymphoma 2 (Bcl-2) and antigen Ki67 
>90%. These findings were consistent with a diagnosis 
 
Figure 2: B-lymphocyte inflitration with a 
predominance of medium size and split non-cleaved 
cells with blastic differentiation.
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of diffuse large B-cell lymphoma, leg type [Figure 2]. In 
addition, testing for the Epstein-Barr virus by in situ 
hybridisation was negative. 
Comment
Diffuse large B-cell lymphoma, leg type is a subset 
of primary cutaneous lymphoma, characterised by 
the presence of nodules or tumours on the legs of 
elderly people, mainly females.1 It represents 1–4% of 
all cutaneous lymphomas and has a five-year survival 
rate of less than 50%.2 This form of lymphoma was 
identified as an independent entity in the classification 
of cutaneous lymphomas developed by the European 
Organisation for Research and Treatment of Cancer.3 
Although these lymphomas are mostly limited to the 
skin at presentation, in 10% of reported cases the 
tumoural lesions begin in locations other than the 
legs.4 When the malignancy spreads, it frequently 
advances to the lymph nodes, bone marrow and the 
central nervous system.4 
As the majority of the patients with this 
condition are elderly, the therapeutical management 
may be complicated due to comorbidities and the 
potentially frequent number of relapses. Spontaneous 
remission only occurs in rare cases.5 Rituximab 
plus cyclophosphamide, doxorubicin, vincristine 
and prednisolone (R-CHOP) chemotherapy and 
chemotherapeutic compounds applied for relapsing 
systemic B-cell non-Hodgkin’s lymphoma have 
previously proven to be effective therapies.6 However, 
the current first line of treatment for this variety of 
lymphoma involves anti-CD20 antibodies, such as 
rituximab. These therapies can be used even during 
the early stages of the condition in order to improve 
rates of survival.7 
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